You are using an outdated browser. Please upgrade your browser to improve your experience.
Karyopharm HCP Connect

Karyopharm HCP Connect is designed with the goal to help inform healthcare providers with key information and resources pertaining to the treatment of selinexor in combination with bortezomib and dexamethasone (XVd) in patients with Multiple Myeloma who have received at least one prior therapy

Karyopharm HCP Connect is designed with the goal to help inform healthcare providers with key information and resources pertaining to the treatment of selinexor in combination with bortezomib and dexamethasone (XVd) in patients with Multiple Myeloma who have received at least one prior therapy

Karyopharm HCP Connect

by Karyopharm Therapeutics Inc
Karyopharm HCP Connect
Karyopharm HCP Connect
Karyopharm HCP Connect

What is it about?

Karyopharm HCP Connect is designed with the goal to help inform healthcare providers with key information and resources pertaining to the treatment of selinexor in combination with bortezomib and dexamethasone (XVd) in patients with Multiple Myeloma who have received at least one prior therapy. The app provides helpful, easily navigable information about selinexor right at your fingertips. Resources within the app include convenient ways to request a discussion with your peers who have extensive selinexor clinical experience as well as to contact your Karyopharm Medical Representatives; BOSTON (XVd) clinical trial design, XVd efficacy & safety data, XVd dosing and dose modification information, detailed supportive care guidance and access to Med Info FAQs.

Karyopharm HCP Connect

App Details

Version
1.0.3
Rating
(1)
Size
75Mb
Genre
Medical
Last updated
July 8, 2021
Release date
May 1, 2021
More info

App Screenshots

Karyopharm HCP Connect screenshot-0
Karyopharm HCP Connect screenshot-1
Karyopharm HCP Connect screenshot-2
Karyopharm HCP Connect screenshot-3

App Store Description

Karyopharm HCP Connect is designed with the goal to help inform healthcare providers with key information and resources pertaining to the treatment of selinexor in combination with bortezomib and dexamethasone (XVd) in patients with Multiple Myeloma who have received at least one prior therapy. The app provides helpful, easily navigable information about selinexor right at your fingertips. Resources within the app include convenient ways to request a discussion with your peers who have extensive selinexor clinical experience as well as to contact your Karyopharm Medical Representatives; BOSTON (XVd) clinical trial design, XVd efficacy & safety data, XVd dosing and dose modification information, detailed supportive care guidance and access to Med Info FAQs.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.